Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Bardot

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|May 28, 2019
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous MetastasisRavan Moret, Linh Hellmers, Xin Zhang, et al.
European Urology|November 5, 2018
Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate CancerDaniel J Canter, Julia Reid, Maria Latsis, et al.
Cancers|May 27, 2026
Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse AvatarsAmita Bhattarai, Ravan Moret, Xin Zhang, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
Clinical Genitourinary Cancer|February 20, 2021
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality TherapyJonathan D Tward, Thorsten Schlomm, Stephen Bardot, et al.
Oncotarget|September 18, 2018
A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasisJessie Gills, Ravan Moret, Xin Zhang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|May 28, 2019
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous MetastasisRavan Moret, Linh Hellmers, Xin Zhang, et al.
European Urology|November 5, 2018
Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate CancerDaniel J Canter, Julia Reid, Maria Latsis, et al.
Cancers|May 27, 2026
Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse AvatarsAmita Bhattarai, Ravan Moret, Xin Zhang, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2019
Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapyDaniel J Canter, Stephen Freedland, Saradha Rajamani, et al.
Clinical Genitourinary Cancer|February 20, 2021
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality TherapyJonathan D Tward, Thorsten Schlomm, Stephen Bardot, et al.
Oncotarget|September 18, 2018
A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasisJessie Gills, Ravan Moret, Xin Zhang, et al.
Pageof 1